Trial Profile
Effect of Different Dosages of Intravitreal Bevacizumab (Avastin) in the Treatment of Diabetic Macular Edema: A Randomized Controlled Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2012
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 08 Jan 2010 New trial record